Edgewise Therapeutics, Inc. Conversion of Stock, Shares Issued
Edgewise Therapeutics, Inc. (EWTX) reported Conversion of Stock, Shares Issued of 1 shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2022-02-24
- Edgewise Therapeutics, Inc. conversion of stock, shares issued for the quarter ending 2021-12-31 was 0.00 shares.
- Edgewise Therapeutics, Inc. conversion of stock, shares issued for the quarter ending 2021-09-30 was 0.00 shares.
- Edgewise Therapeutics, Inc. conversion of stock, shares issued for the quarter ending 2021-06-30 was 0.00 shares.
- Edgewise Therapeutics, Inc. conversion of stock, shares issued for the quarter ending 2021-03-31 was 1.00 shares.
- Edgewise Therapeutics, Inc. conversion of stock, shares issued for fiscal 2021 was 1.00 shares.
| Period end | Conversion of Stock, Shares Issued 3 month | Conversion of Stock, Shares Issued 6 month | Conversion of Stock, Shares Issued 9 month | Conversion of Stock, Shares Issued 12 month |
|---|---|---|---|---|
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 0.00 shares derived: sum of 2 quarters · filed 2022-02-24 | 0.00 shares derived: sum of 3 quarters · filed 2022-02-24 | 1.00 shares 10-K · filed 2022-02-24 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 0.00 shares derived: sum of 2 quarters · filed 2021-11-10 | 1.00 shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 1.00 shares 10-Q · filed 2021-08-09 | ||
| 2021-03-31 | 1.00 shares 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 |